Medical device failures - Can we learn from our mistakes?

Medical Device Materials II - Proceedings of the Materials and Processes for Medical Devices Conference 2004

Volumn , Issue , 2005, Pages 3-11

  Eiselstem, L E ^a   James, B ^a  

^a EXPONENT INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOMEDICAL ENGINEERING; HEART VALVE PROSTHESES; PACEMAKERS;

IMPLANTABLE DEVICES; MECHANICAL FAILURES;

BIOMEDICAL EQUIPMENT;

EID: 31744434633     PISSN: None     EISSN: None     Source Type: Conference Proceeding    
DOI: None     Document Type: Conference Paper

References (62)

1. Petroski, H., To Err is Human. 1984, New York: St. Martin's Press.
2. GAO, Medical Devices: FDA Can Improve Oversight of Tracking and Recall Systems. 1998, General Accounting Office: Washington, D.C.
3. Nair, K., C.V. Muraleedharan, and G.S. Bhuvaneshwar, Developments in mechanical heart valve prosthesis. Sadhana, 2003. 28(Parts 3&4): p. 575-587.
4. Matthews, A.M., The Development of Starr-Edwards Heart Valve. Texas Heart Institute Journal, 1998. 25: p. 282-293.
5. Muller, W.A., L.H. Cohn, and F.J. Schoen, Infection within a degenerated Starr-Edwards silicone rubber poppet in the aortic valve position. Am J Cardiol, 1984. 54(8): p. 1146.
6. McMillin, C.R., Mechanical Breakdown in the Biological Environment, in Biomaterials Science: An Introduction to Materials in Medicine, B.D. Ratner, et al., Editors. 1996, Academic Press: San Diego, CA.
7. Mazzucco, A., et al., Ball fracture with the 6120-model Starr-Edwards mitral valve prosthesis occurring late after implantation. J Heart Valve Dis, 1993. 2(2): p. 245-7.
8. Grunkemeier, G.L. and A. Starr, Late ball variance with the Model 1000 Starr-Edwards aortic valve prosthesis. Risk analysis and strategy of operative management. J Thorac Cardiovasc Surg, 1986. 91(6): p. 918-23.
9. Freimanis, I. and A. Starr, The unnatural history of valvular heart disease: late results with silastic ball valve prostheses. J Cardiovasc Surg (Torino), 1984. 25(3): p. 191-8.
10. Connolly, D.C., C.E. Harrison, Jr., and F.H. Ellis, Jr., Ball variance in a Starr-Edwards prosthetic mitral valve causing acute pulmonary edema (diagnosis by auscultation before onset of symptoms). Mayo Clin Proc, 1970. 45(1): p. 20-4.
11. Roberts, W.C., G.E. Levinson, and A.G. Morrow, Lethal ball variance in the Starr-Edwards prosthetic mitral valve. Arch Intern Med, 1970. 126(3): p. 517-21.
12. Roberts, W.C. and A.G. Morrow, Fatal degeneration of the silicone rubber ball of the Starr-Edwards prosthetic aortic valve. Am J Cardiol, 1968. 22(5): p. 614-20.
13. Fiegenberg, D.S., J.A. DeColli, and P.R. Lisan, Fracture of a Starr-Edwards aortic ball valve with systemic embolism of ball fragments. Am J Cardiol, 1969. 23(3): p. 458-63.
14. Fielder, J.H., Defects and Deceptions - The Bjork-Shiley Heart Valve. IEEE Technology and Society, 1995. 14(3): p. 17-20.
15. Dodd, D.S., Long-term performance of Polyurethane leads; the genesis and reparation of an industry prejudice. 1998, Scientific and Clinical Studies: Palm Coast, FL.
16. Stokes, K.B. and T. Church, Ten-year experience with implanted polyurethane lead Insulation. Pacing Clin Electrophysiol, 1986. 9(6 Pt 2): p. 1160-5.
17. Szycher, M. and W. McArthur. Surface Fissuring of Polyurethanes Following In Vivo Exposure. in Corrosion and Degradation of Implant Materials: Second Symposium. 1985. Philadelphia: American Society for Testing and Materials.
18. Stokes, K.B., Polyether polyurethanes: biostable or not? J Biomater Appl, 1988. 3(2): p. 228-59.
19. Parins, D., et al. In Vivo Degradation of a Polyurethane: Preclinical Studies. in Corrosion and Degradation of Implant Materials: Second Symposium. 1985. Philadelphia: American Society for Testing and Materials.
20. Stokes, K.B., The biostability of polyurethane leads, in Modern Cardiac Pacing, S.S. Barold, Editor. 1985, Futura Publishing: Mt.Kisco, NY. p. 173-198.
21. Furman, S., et al., Long-term follow-up of pacemaker lead systems: establishment of standards of quality. Pacing Clin Electrophysiol, 1995. 18(2): p. 271-85.
22. Hayes, D.L., et al., Multicenter experience with a bipolar fined polyurethane ventricular lead. Pacing Clin Electrophysiol, 1995. 18(5 Pt 1): p. 999-1004.
23. Ezrin, M., Medical Applications, in Plastic Failure Guide: Causes and Preventions. 1996, Hanser: New York.
24. Phillips, R., M. Frey, and R.O. Martin, Long-term performance of polyurethane pacing leads: mechanisms of design-related failures. Pacing Clin Electrophysiol, 1986. 9(6 Pt 2): p. 1166-72.
25. Wiggins, M.J., J.M. Anderson, and A. Hiltner, Biodegradation of polyurethane under fatigue loading. J Biomed Mater Res, 2003. 65A(4): p. 524-35.
26. Wiggins, M.J., J.M. Anderson, and A. Hiltner, Effect of strain and strain rate on fatigue-accelerated biodegradation of polyurethane. J Biomed Mater Res, 2003. 66A(3): p. 463-75.
27. Stokes, K.B. and M.W. Davis, Environmental Stress Cracking in Implanted Polyurethane Devices, in Advances in Biomedical Polymers, Polymer Science and Technologies, G. Gebelein, Editor. 1987, Plenum: New York.
28. Tyers, G.F., et al., Bipolar leads for use with permanently implantable cardiac pacing systems: a review of limitations of traditional and coaxial configurations and the development and testing of new conductor, insulation, and electrode designs. J Invest Surg, 1997. 10(1-2): p. 1-15.
29. Byrd, C.L., et al., Implant experience with unipolar polyurethane pacing leads. Pacing Clin Electrophysiol, 1983. 6(5 Pt 1): p. 869-82.
30. Thoma, R.J., Poly(ether) urethane reactivity with metal-ion in calcification and environmental stress cracking. J Biomater Appl, 1987. 1(4): p. 449-86.
31. Wiggins, M.J., et al., Biodegradation of polyether polyurethane inner insulation in bipolar pacemaker leads. J Biomed Mater Res, 2001. 58(3): p. 302-7.
32. CDRH, Guidance for Submission of Research and Marketing Applications for Permanent Pacemaker Leads and for Pacemaker Lead Adaptor 510(k) Submissions. 2000, Food and Drug Administration Center for Devices and Radiological Health: Rockville, MB.
33. Meijs, G.F., P.A. Gunatillake, and S.J. McCarthy, United States Patent 6,627,724: Polysiloxane-containing polyurethane elastomeric compositions. 2003.
34. Lyster, M., Seeking happy end to Shiley legacy. ' Orange County Business Journal, 1997. 20(7).
35. ASM, Metallic Materials, in Handbook of Materials for Medical Devices, J.R. Davis, Editor. 2003, ASM International: Materials Park, Ohio.
36. Piehler, H.R., The Future of Medicine: Biomaterials, Materials Challenges for the Next Century. MRS Bulletin, 2000. 25(8): p. 67-70.
37. US Congress, The Bjork-Shiley Heart Valve: Earn as You Learn. 1990, Subcommittee on Oversight and Investigations House Committee on Energy and Commerce.
38. US Congress, FDA and the Medical Device Industry. 1990, Hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce House of Representatives 101st Congress Second Session.
39. Omar, R.Z., et al., Outlet strut fracture of Bjork-Shiley convexo-concave valves: can valve-manufacturing characteristics explain the risk? J Thorac Cardiovasc Surg, 2001. 121(6): p. 1143-9.
40. Omar, R.Z., et al., Outlet strut fracture of Bjork-Shiley convexo concave heart valves: the UK cohort study. Heart, 2001. 86(1): p. 57-62.
41. Omar, R.Z., et al., Use of flexibility tests in the manufacturing process of 60 degrees Bjork-Shiley convexo-concave valves and the risk of outlet strut fracture. J Thorac Cardiovasc Surg, 2003. 126(3): p. 832-6.
42. Meier, B., Pfizer Unit to Settle Charges of Lying About Heart Valve, in New York Times. 1994.
43. de Mol, B.A., et al., Single-leg strut fractures in explanted Bjork-Shiley valves. Lancet, 1994. 343(8888): p. 9-12.
44. Wieting, D.W., et al., Strut fracture mechanisms of the Bjork-Shiley convexo-concave heart valve. J Heart Valve Dis, 1999. 8(2): p. 206-17.
45. Morton, L., et al., Importance of emergency identification schemes. Emerg Med J, 2002. 19(6): p. 584-6.
46. Mera, F., P. Walter, and J. Langberg, Protrusion without fracture of the Accufix atrial "J" lead retention wire. J Cardiovasc Electrophysiol, 1997. 8(9): p. 1062-4.
47. Kay, G.N., et al., Risks of spontaneous injury and extraction of an active fixation pacemaker lead: report of the Accufix Multicenter Clinical Study and Worldwide Registry. Circulation, 1999. 100(23): p. 2344-52.
48. Ardesia, R.J., B.C. Saliba, and M.H. Schoenfeld, Evolution of fracture in the atrial "J" lead retention wire. Pacing Clin Electrophysiol, 1995. 18(12 Pt 1): p. 2227-8.
49. Brinker, J.A., Endocardial pacing leads: the good, the bad, and the ugly. Pacing Clin Electrophysiol, 1995. 18(5 Pt 1): p. 953-4.
50. Glikson, M., et al., Clinical surveillance of an active fixation, bipolar, polyurethane insulated pacing lead, Part I: The atrial lead. Pacing Clin Electrophysiol, 1994. 17(8): p. 1399-404.
51. Glikson, M., et al., Clinical surveillance of an active fixation, bipolar, polyurethane insulated pacing lead, Part II: The ventricular lead. Pacing Clin Electrophysiol, 1994. 17(9): p. 1499-502.
52. Hayes, D.L., M.A. Lloyd, and D.R. Holmes, Jr., Counseling and management of patients with Telectronics 330-801 Accufix leads. Pacing Clin Electrophysiol, 1995. 18(8): p. 1595.
53. Parsonnet, V., Telectronics 330-801 lead extraction. Ann Thorac Surg, 1998. 65(2): p. 600-1.
54. Kantharia, B.K. and S.P. Kutalek, Extraction of pacemaker and implantable cardioverter defibrillator leads. Curr Opin Cardiol, 1999. 14(1): p. 44-51.
55. O'Malley, K., United States District Court Northern District of Ohio Eastern Division In Re: Sulzer Hip Prosthesis and Knee Prosthesis Liability Litigation. 2001.
56. Exponent, Failure and Risk Analysis Case Study #2: Voluntary Recall of Total Hip Replacement. 2004, Exponent: Boston.
57. Spiegelberg, S.H., K.J. Deluzio, and O.K. Muratogul. Poster #1346: Extractable Residue from Recalled Inter-Op Acetabular Shells. in 49th Annual Meeting of the Orthopaedic Research Society. 2003. New Orleans, LA.
58. Spiegelberg, S.H. Current Activities in Cleanliness of Biomedical Devices at ASTM. in ASTM Workshop on Cleanliness of Biomedical Devices. 2003. Kansas City, MO.
59. Campbell, P. and J. Mirra. Histopathology of Failed Inter-Op Acetabular Components. in ASTM Workshop on Cleanliness Issues in Medical Devices. 2003. Kansas City, MO.
60. Sulzer, Sulzer Implant Settlement - Class Member and Attorney Guide. 2003, 2003 - Sulzer Settlement Trust.
61. Immel, B., A Brief History of the GMPs. BioPharm Magazine, 2000(August).
62. FDA, FDA Milestones in Women's Health: Looking Back as We Move into the New Millennium. 2001, FDA: Washington, DC.